Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

OBJECTIVE: We investigated prolonged COVID-19 symptom duration, defined as lasting 28 days or longer, among people with systemic autoimmune rheumatic diseases (SARDs). METHODS: We analysed data from the COVID-19 Global Rheumatology Alliance Vaccine Survey (2 April 2021–15 October 2021) to identify p...

Descripción completa

Detalles Bibliográficos
Autores principales: DiIorio, Michael, Kennedy, Kevin, Liew, Jean W, Putman, Michael S, Sirotich, Emily, Sattui, Sebastian E, Foster, Gary, Harrison, Carly, Larché, Maggie J, Levine, Mitchell, Moni, Tarin T, Thabane, Lehana, Bhana, Suleman, Costello, Wendy, Grainger, Rebecca, Machado, Pedro M, Robinson, Philip C, Sufka, Paul, Wallace, Zachary S, Yazdany, Jinoos, Gore-Massy, Monique, Howard, Richard A, Kodhek, More A, Lalonde, Nadine, Tomasella, Laura-Ann, Wallace, John, Akpabio, Akpabio, Alpízar-Rodríguez, Deshiré, Beesley, Richard P, Berenbaum, Francis, Bulina, Inita, Chock, Eugenia Yupei, Conway, Richard, Duarte-García, Alí, Duff, Eimear, Gheita, Tamer A, Graef, Elizabeth R, Hsieh, Evelyn, El Kibbi, Lina, Liew, David FL, Lo, Chieh, Nudel, Michal, Singh, Aman Dev, Singh, Jasvinder A, Singh, Namrata, Ugarte-Gil, Manuel F, Hausmann, Jonathan S, Simard, Julia F, Sparks, Jeffrey A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475962/
https://www.ncbi.nlm.nih.gov/pubmed/36104117
http://dx.doi.org/10.1136/rmdopen-2022-002587

Ejemplares similares

Ejemplares similares